Skip to main content

Table 1 Patient characteristics at baseline

From: Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study—the CARDOVID registry

  Total
n = 111
Myocarditis
(Group 1)
(n = 20)
No myocarditis (Group 2)
(n = 91)
p-value
Female 42 (38) 7 (35) 35 (38) 0.999
Ethnicity     0.203
Caucasian 36/100 (36) 10/19 (53) 26/81 (32)  
Afro-American 45/100 (45) 5/19 (26) 40/81 (49)  
Asian 8/100 (8) 1/19 (5) 7/81 (9)  
Hispanic 11/100 (11) 3/19 (16) 8/81 (10)  
Age at symptom onset, years 10.0 (7.0–13.8) 10.7 (7.5–16.0) 10.0 (7.0–13.0) 0.370
Comorbiditya 25/106 (24) 6/19 (32) 19/87 (22) 0.380
COVID serology positive 96/98 (98) 18/18 (100) 78/80 (98) 0.999
COVID PCR and serology positive 30/111 (27) 4/20 (20) 26/91 (29) 0.611
Duration between symptom onset and hospital admission, days 5 (4–6) 4 (4–6) 5 (4–6) 0.200
Follow-up duration (days) 55 (43–100) 53 (39–81) 58 (44–105) 0.641
  1. Values are presented as absolute numbers (%) or medians (IQR). NA = not available. The denominator for each field is reflective of the total number of available data entry points
  2. aAssociated comorbidities (cumulative): pulmonary (bronchiolitis, asthma) n = 16, autism n = 2, overweight/obesity n = 8, and history of myocarditis, chronic tuberculosis, psoriasis, arterial hypertension, systemic lupus, congenital adrenal hyperplasia by 21-hydroxylase deficiency, alopecia areata n = 1 each